About this episode

This episode discusses Cerebrolysin, its clinical research, and its controversial status in the biohacking community.

Cerebrolysin is a complex biological compound derived from porcine brain tissue that is primarily used to support neurological recovery and cognitive function. Unlike many experimental peptides, this substance has undergone decades of clinical research regarding its impact on stroke, dementia, and traumatic brain injuries . While it is approved for medical use in over forty countries, it remains unauthorized by the FDA , and its overall effectiveness is still debated due to inconsistent trial results . Within the biohacking community , it is highly regarded for its potential to enhance neuroplasticity and mental clarity , though these anecdotal benefits often exceed what is scientifically proven. Ultimately, the sources highlight a significant gap between promising clinical observations and the more extreme claims of total brain regeneration found online.

Topics covered

• neurological recovery
• cognitive function
• clinical research
• biohacking
• neuroplasticity
• mental clarity

Keywords

• Cerebrolysin
• neurological recovery
• cognitive function
• biohacking
• neuroplasticity
• mental clarity
• clinical research

Mentioned in this episode

Organizations: FDA

Products: Cerebrolysin

Places: porcine

More episodes of Today's discussion

• Pinealon: The Science and Hype of Brain Bioregulators · September 7, 2026 · 21 min
• Dulaglutide: The Foundation of Modern Metabolic Medicine · August 31, 2026 · 21 min
• FOXO4-DRI: The Science and Hype of Senolytic Peptides · August 24, 2026 · 26 min
• ADAMAX Peptide: Science, Hype, and Cognitive Potential · August 10, 2026 · 19 min
• Survodutide: The Metabolic Power of Dual Receptor Agonism · August 3, 2026 · 20 min
• DT-109: The Tripeptide Frontier of Metabolic Health · July 27, 2026 · 23 min

Explore listener stats, chart rankings, contacts and more on the Today's discussion podcast page.